Differential retinoic acid radiosensitization of cervical carcinoma cell lines

Clinical Cancer Research

Volumn 3, Issue 6, 1997, Pages 939-945

  Benbrook, Doris M ^a   Shen Gunther, Jane ^a   Nuñez, Evelyn R ^a   Dynlacht, Joseph R ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID;

ARTICLE; CELL CYCLE PHASE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIZATION; TUMOR CELL LINE; UTERINE CERVIX CARCINOMA;

CELL CYCLE; CELL DIVISION; CELL SURVIVAL; COBALT RADIOISOTOPES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; TRETINOIN; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0030911085     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Wingo, P. A., Tong, T. S., and Bolden, B. A. Cancer statistics. CA Cancer J. Clin., 45: 8-30, 1995.
2. Koss, L. G. Cervical (Pap) smear. Cancer (Phila.), 71: 1406-1412, 1993.
3. Jampolis, S., Andras, J., and Fletcher, G. H. Analysis of sites and causes of failure of irradiation in invasive squamous cell carcinoma of the intact uterine cervix. Radiology, 115: 681-685, 1974.
4. Shingleton, H. M., Orr, J. W. Radiation therapy. In: Lisa McAllister, Emille Moyer Linkins, and Ellen M. Campbell (eds.), Cancer of the Cervix, pp. 155-200. Philadelphia: J. B. Lippincott Co., 1995.
5. Shingleton, H. M., and Orr, J. W. Other treatments. In: Lisa McAllister, Emille Moyer Linkins, and Ellen M. Campbell (eds.), Cancer of the Cervix, pp. 201-222. Philadelphia: J. B. Lippincott Co., 1995.
6. zur Hausen, H. Papillomaviruses in human cancer. Mol. Carcinog., 1: 147-150, 1988.
7. Baker, C. C., Phelps, W. W., Lindgren, V., Braun, M. J., Gonda, M. A., and Howley, P. M. Structural and translational analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol., 61: 962-971, 1987.
8. White, A. E., Livanos, E. M., and Tlsty, T. D. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev., 8: 666-677, 1994.
9. Pirisi, L., Batova, A., Jenkins, G. R., Hodam, J. R., and Creek, K. E. Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids. Cancer Res., 52: 187-193, 1992.
10. Bartsch, D., Boye, B., Baust, C., zur Hausen, H., and Schwarz, E. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor β gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J., 11: 2283-2291, 1992.
11. Goss, G. D., and McBurney, M. W. Physiological and clinical aspects of vitamin A and its metabolites. Crit. Rev. Clin. Lab. Sci., 29: 185-215, 1992.
12. Lippman, S. M., Kavanagh, J. J., Paredes-Espinosa, M., Delgadillo-Madrueno, F., Paredes-Casillas, P., Hong, W. K., Holdener, E., and Krakoff, I. H. 13-cis retinoic acid plus interferon α-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J. Natl. Cancer Inst., 84: 241-245, 1992.
13. Lippman, S. M., Kavanagh, J. J., Paredes-Espinosa, M., Delgadillo-Madrueno, F., Paredes-Casillas, P., Hong, W. K., Massimini, G., Holdener, E. E., Krakoff, I. H. 13-cis retinoic acid plus interferon-α-2a in locally advanced squamous cell carcinoma of the cervix. J. Natl. Cancer Inst., 85: 499-500, 1993.
14. Romney, S. L., Palan, P. R., Duttagupta, C., Wassertheil-Smoller, S., and Lucido, D. Retinoids and the prevention of cervical dysplasias. Am. J. Obstet. Gynecol., 141: 890-894, 1981.
15. Meyskens, F. L., Graham, V., Chvapil, M., Dorr, R. T., Alberts, D. S., and Surwit, E. A. A phase I trial of β-all-trans-retinoic acid delivered via collagen sponge and cervical cap for mild or moderate intraepithelial cervical neoplasia. J. Natl. Cancer Inst., 71: 921-925, 1983.
16. Graham, V., Surwit, E. S., Weiner, S., and Meyskens, F. L. Phase II trial of β-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via collagen sponge and cervical cap. West. J. Med., 145: 192-195, 1986.
17. Meyskens, F. L., and Surwit, E. S. Clinical experience with topical tretinoin in the treatment of cervical dysplasia. J. Am. Acad. Dermatol., 15: 826-829, 1986.
18. Weiner, S. A., Surwit, E. A., Graham, V. E., and Meyskens, F. L. A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy. Invest. New Drugs, 4: 241-244, 1986.
19. Pirisi, L., Batova, A., Jenkins, G. R., Hodam, J. R., and Creek, K. E. Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids. Cancer Res., 52: 187-193, 1992.
20. Lotan, R., Neumann, G., and Lotan, D. Characterization of retinoic acid-induced alterations in the proliferation and differentiation of a murine and a human melanoma cell line in culture. Ann. NY Acad. Sci., 359: 150-170, 1981.
21. Preisler, H. D., Gopal, V., Banavali, S. D., Finke, D., and Bokari, S. A. Multiparameter assessment of the cell cycle effects of bioactive and cytotoxic agents. Cancer Res., 52: 4090-4095, 1992.
22. Ahao, A., Ahang, A. P., Soprano, D. R., and Soprano, K. J. Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells. Exp. Cell. Res., 219: 555-561, 1995.
23. Hall, E. J. Radiosensitivity and cell age in the mitotic cycle. In: J. D. Ryan, K. Cox, and D. Papadopoulos (eds.), Radiobiology for the Radiobiologist, Ed. 4, pp. 91-106. Philadelphia: J. B. Lippincott Company, 1994.
24. Benbrook, D., Rogers, R., Medlin, M., and Dunn, S. T. Immunohistochemical analysis of differentiation and proliferation in organotypic cultures of cervical tumor cell lines. Tissue Cell, 27: 269-274, 1995.
25. Hall, E. J. Cell Survival Curves. In: J. D. Ryan, K. Cox, and D. Papadopoulos (eds.), Radiobiology for the Radiobiologist, Ed. 4, pp. 29-43. Philadelphia: J. B. Lippincott Company, 1994.
26. Kitabayashi, I., Chiu, R., Umesono, K., Evans, R. M., Gachelin, G., and Yokoyama, K. A novel pathway for retinoic acid-induced differentiation of F9 cells that is distinct from receptor-mediated trans-activation. In Vitro Cell. Dev. Biol., 30A: 761-768, 1994.
27. Reiss, M., Dibble, C. L., and Sartorelli, A. C. Down-regulation of glucocorticoid binding sites by retinoic acid in squamous carcinoma cells resistant to the induction of keratinization by hydrocortisone. J. Invest. Dermatol., 91: 344-349, 1988.
28. Hall, E. J. Repair of radiation damage and the dose-rate effect. In: J. D. Ryan, K. Cox, and D. Papadopoulos (eds.), Radiobiology for the Radiobiologist. Ed. 4, pp. 107-131. Philadelphia: J. B. Lippincott Company, 1994.
29. 2-delay after irradiation. Radiat. Res., 138: S64-S67, 1994.
30. Kwok, T. T., and Sutherland, R. M. Differences in EGF related radiosensitization of human squamous carcinoma cells with high and low numbers of EGF receptors. Br. J. Cancer, 251: 251-254, 1991.
31. Quilty, P., Kerr, G. R., and Duncan, W. Prognostic indices for bladder cancer: an analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray. Radiother. Oncol., 7: 311-322, 1986.
32. Martin, J. E., Jenkins, B. J., Zuk, R. J., Blandy, J. P., and Baithun, S. I. Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder. J. Clin. Pathol., 42: 250-253, 1989.
33. Rofstad, E. K., and Sutherland, R. M. Radiation sensitivity of human ovarian carcinoma cell lines in vitro: effects of growth factors and hormones, basement membrane, and intercellular contact. Int. J. Radiat. Oncol. Biol. Phys., 15: 921-929, 1988.
34. Duchesne, G. M., and Hutchinson, L. K. Reversible changes in radiation response induced by all-trans retinoic acid. Int. J. Radiat. Oncol. Biol. Phys., 33: 875-880, 1995.
35. Maity, A., McKenna, W. G., and Muschel, R. J. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother. Oncol., 31: 1-13, 1994.
36. Kessis, T. D., Slebos, R. J., Nelson, W. G., Kastan, M. B., Plunkett, B. S., Man, S. M., Lorincz, A. T., Hedrick, L., and Cho, K. R. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. USA, 90: 3988-3992, 1993.
37. Morris, J. D. H., Crook, T., Bandara, L. R., Davies, R., LaThangue, N. B., and Vousden, K. H. Human papillomavirus type 16 E7 regulates E2F and contributes to mitogenic signaling. Oncogene, 8: 893-898, 1993.
38. Oridate, N., Lotan, D., Mitchell, M. F., Hong, W. K., and Lotan, R. Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implication for chemoprevention. J. Cell. Biochem. Suppl., 23: 80-86, 1995.
39. Rutz, H. P. Little, J. B. Modification of radiosensitivity and recovery from X-ray damage in vitro by retinoic acid. Int. J. Radiat. Oncol. Biol. Phys. 16: 1285-1288, 1989.
40. Sanford, K. K., Parshad, R., Price, F. M., Tarone, R. E., and Kraemer, K. H. Retinoid protection against X-ray induced chromatid damage in human peripheral blood lymphocytes. J. Clin. Invest., 90: 2069-2074, 1992.
41. Sheldon, P. W., Foster, J. L., and Fowler, J. F. Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug. Br. J. Cancer. 30: 560-565, 1974.
42. Fertil, B., and Malaise, E. P. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 7: 621-629, 1981.
43. Deacon, J., Peckham, M. J., and Steel, G. G. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother. Oncol., 2: 317-323, 1984.
44. Fertil, B., and Malaise, E. P. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int. J. Radiat. Oncol. Biol. Phys., 11: 1699-1707, 1985.
45. Rofstad, E. K., and Brustad, T. Radioresponsiveness of human melanoma xenografts given fractionated irradiation in vivo: relationship to the initial slope of the cell survival curves in vitro. Radiother. Oncol., 9: 45-56, 1987.
46. Liebman, J., Cook, J. A., Fisher, J., Teague, D., and Mitchell, J. B. Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol®). Int. J. Radiat. Oncol. Biol. Phys., 29: 559-564, 1994.